Patents Represented by Attorney, Agent or Law Firm David P. Lenti
  • Method of treating a urokinase-type plasminogen activator-mediated disorder
    Patent number: 6248715
    Abstract: A method of treating an uPA-mediated disorder is disclosed, which comprises providing and administering an effective amount of polypeptide consisting essentially of the EGF-like domain of human uPA or active analog thereof.
    Type: Grant
    Filed: May 10, 1995
    Date of Patent: June 19, 2001
    Assignee: Chiron Corporation
    Inventors: Steven Rosenberg, Jennifer R. Stratton-Thomas